The National Heart, Lung, and Blood Institute (NHLBI) would like to inform physicians and researchers of two new and exciting funding opportunities upcoming in 2020. NHLBI has released the following “Notices of Intent” to provide interested parties advanced word of these significant awards. Follow the links below to learn more.

Notice of Intent to Publish a Funding Opportunity Announcement for Generate A Precision Medicine Intergenerational Resource for the Study of Factor VIII Immunogenicity in Severe Hemophilia A: Clinical Coordinating Center.

Notice of Intent to Publish a Funding Opportunity Announcement for Generate an Intergenerational Precision Medicine Resource for the Study of Factor VIII Immunogenicity in Severe Hemophilia A: Biospecimen and Data Resource Center (U24).

The estimated publication date of the official funding opportunity announcement for both awards is March 2, 2020. Please direct all requests for information to: FactorVIII@DBDR.NIH.NHLBI.gov.

Recent News

Medical
Doctor with bones hands
New Documents Cover Bleeding Disorders, Bone Health, Mental Health Facility Access
Medical
Red Blood cells moving in bloodstream
FDA Approves Pfizer's HYMPAVZI for Hemophilia A and B Treatment
Medical
Webinar Banner
Support Networks and Clinical Trials the Focus of Upcoming FDA Webinar
Medical
Durability of FactorVIII Focus of New Hemophilia A Gene Therapy Study
CHOP Researchers Investigate Durability of Hemophilia A Gene Therapy